Cargando…

Cabergoline Treatment in Invasive Giant Prolactinoma

Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsubaie, Sadeem, Almalki, Mussa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076446/
https://www.ncbi.nlm.nih.gov/pubmed/25002819
http://dx.doi.org/10.4137/CCRep.S15790
_version_ 1782323485080551424
author Alsubaie, Sadeem
Almalki, Mussa H
author_facet Alsubaie, Sadeem
Almalki, Mussa H
author_sort Alsubaie, Sadeem
collection PubMed
description Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically.
format Online
Article
Text
id pubmed-4076446
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-40764462014-07-07 Cabergoline Treatment in Invasive Giant Prolactinoma Alsubaie, Sadeem Almalki, Mussa H Clin Med Insights Case Rep Case Report Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically. Libertas Academica 2014-06-19 /pmc/articles/PMC4076446/ /pubmed/25002819 http://dx.doi.org/10.4137/CCRep.S15790 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article published under the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Case Report
Alsubaie, Sadeem
Almalki, Mussa H
Cabergoline Treatment in Invasive Giant Prolactinoma
title Cabergoline Treatment in Invasive Giant Prolactinoma
title_full Cabergoline Treatment in Invasive Giant Prolactinoma
title_fullStr Cabergoline Treatment in Invasive Giant Prolactinoma
title_full_unstemmed Cabergoline Treatment in Invasive Giant Prolactinoma
title_short Cabergoline Treatment in Invasive Giant Prolactinoma
title_sort cabergoline treatment in invasive giant prolactinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076446/
https://www.ncbi.nlm.nih.gov/pubmed/25002819
http://dx.doi.org/10.4137/CCRep.S15790
work_keys_str_mv AT alsubaiesadeem cabergolinetreatmentininvasivegiantprolactinoma
AT almalkimussah cabergolinetreatmentininvasivegiantprolactinoma